Article
How to improve AML outcomes?
1 Dec 2024
Abstract excerpt
Understanding the intricacies of the pathophysiology and genomic landscape has enhanced the long-term outcomes for patients with acute myeloid leukemia (AML). The identification of novel molecular targets has introduced new therapeutic strategies that attempt to surpass the dominance of the "7 + 3 regimen" established in the 1970s. In 2022, the World Health Organization and International Consensus Classification...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
